NEW YORK (GenomeWeb News) – A new report released yesterday by the Agency for Healthcare Research and Quality found insufficient evidence that genetic tests for two gene mutations help prevent deep-vein thrombosis, a condition that includes blood clots in the leg and pelvis and can lead to death.

Researchers at the Johns Hopkins Evidence-based Practice Center were unable to find any studies that directly addressed the effect of genetic tests for two mutations, including Factor V Leiden and prothrombin G20210A mutations, AHRQ said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.